17 β Estradiol Modulates Perfusion Pressure and Expression of 5-LOX and CYP450 4A in the Isolated Kidney of Metabolic Syndrome Female Rats

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Zuniga Munoz A M ^a   Guarner Lans, V ^a   Soria Castro, E ^a   Diaz Diaz, E ^b   Torrico Lavayen, R ^a   Tena Betancourt, E ^c   Perez Torres I ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c UNIVERSIDAD LA SALLE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; BAICALEIN; CYTOCHROME P450 4A; ESTRADIOL; INDOMETACIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; MICONAZOLE; PHOSPHOLIPASE A2; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE CLEARANCE; ELECTRON MICROSCOPY; FATTY ACID METABOLISM; FEMALE; HISTOLOGY; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INTRAABDOMINAL FAT; ISOLATED KIDNEY; KIDNEY DISEASE; KIDNEY PERFUSION; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; SYSTOLIC BLOOD PRESSURE;

EID: 84944236951     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/149408     Document Type: Article

References (54)

1. R. Parikh and M. V. Mohan, "Changing definitions ofmetabolic syndrome, " Indian Journal of Endocrinology and Metabolism, vol. 16, no. 1, pp. 7-12, 2012.
2. S. M. Grundy, "Metabolic syndrome pandemic, " Arteriosclerosis, Thrombosis, andVascular Biology, vol. 28, no. 4, pp.629-636, 2008.
3. J. Segura, C. Campo, C. Roldán et al., "Hypertensive renal damage in metabolic syndrome is associated with glucose metabolism disturbances, " Journal of the American Society of Nephrology, vol. 15, no. 1, pp. S37-S42, 2004.
4. I. Pérez-Torres, M. ElHafidi, N. Pavón, O. Infante, M. C. Avila-Casado, and G. Bãnos, "Effect of gonadectomy on the metabolism of arachidonic acid in isolated kidney of a rat model of metabolic syndrome, " Metabolism: Clinical and Experimental, vol. 59, no. 3, pp. 414-423, 2010.
5. G.M. Fischer andM. L. Swain, "Effectof sexhormones onblood pressure and vascular connective tissue in castrated and non castrated male rats, " The American Journal of Physiology, vol. 232, no. 6, pp. H617-H621, 1977.
6. I. Pérez-Torres, P. Roque, M. El Hafidi, E. Diaz-Diaz, and G. Bãnos, "Association of renal damage and oxidative stress in a rat model of metabolic syndrome. Influence of gender, " Free Radical Research, vol. 43, no. 8, pp. 761-771, 2009.
7. A. Dixon and C. Maric, "17-estradiol attenuates diabetic kidney disease by regulating extracellularmatrix and transforming growth factor- protein expression and signaling, " American Journal of Physiology-Renal Physiology, vol. 293, no. 5, pp. F1678-F1690, 2007.
8. R. M. Mason and N. A. Wahab, "Extracellularmatrixmetabolism in diabetic nephropathy, " Journal of the American Society of Nephrology, vol. 14, no. 5, pp. 1358-1373, 2003.
9. A. C. Duncan, J. R. Petrie, M. J. Brosnan et al., "Is estradiol cardioprotection a nitric oxide-mediated effect?" Human Reproduction, vol. 17, no. 7, pp. 1918-1924, 2002.
10. K. Node, M. Kitakase, H. Kosaka et al., "Roles of NO and Ca2+-Activated K+ channels in coronary vasodilation induced by 17beta-estradiol in ischemic heart failure, " The FASEB Journal, vol. 11, no. 10, pp. 793-799, 1997.
11. M. Rosselli, B. Imthurm, E. Macas, P. J. Keller, and R. K. Dubey, "Circulating nitrite/nitrate levels increase with follicular development: indirect evidence for estradiol mediated NO release, " Biochemical and Biophysical Research Communications, vol. 202, no. 3, pp. 1543-1552, 1994.
12. J. Busserolles, A. Mazur, E. Gueux, E. Rock, and Y. Rayssiguier, "Metabolic syndrome in the rat: females are protected against the pro-oxidant effect of a high sucrose diet, " Experimental Biology and Medicine, vol. 227, no. 9, pp. 837-842, 2002.
13. C.-M. Hao and M.D. Breyer, "Physiologic and pathophysiologic roles of lipid mediators in the kidney, " Kidney International, vol. 71, no. 11, pp. 1105-1115, 2007.
14. E. Marcantoni, L. Di Francesco, L. Totani et al., "Effects of estrogen on endothelial prostanoid production and cyclooxygenase-2 and heme oxygenase-1 expression, " Prostaglandins and Other Lipid Mediators, vol. 98, no. 3-4, pp. 122-128, 2012.
15. G. M. Reaven and H. Ho, "Sugar-induced hypertension in Sprague-Dawley rats, " American Journal of Hypertension, vol. 4, no. 7, pp. 610-614, 1991.
16. G. Bãnos, K. Carvajal, G. Cardoso, J. Zamora, and M. Franco, "Vascular reactivity and effect of serum in a rat model of hypertriglyceridemia and hypertension, " American Journal of Hypertension, vol. 10, no. 4, part 1, pp. 379-388, 1997.
17. G. Banos, O. N. Medina-Campos, P. D. Maldonado et al., "Activities of antioxidant enzymes in two stages of pathology development in sucrose-fed rats, " Canadian Journal of Physiology and Pharmacology, vol. 83, no. 3, pp. 278-286, 2005.
18. D. F. Kohn and C. B. Clifford, "Biology and diseases of rats, " in Laboratory AnimalMedicine, pp. 121-158, Elsevier Science, New York, NY, USA, 2nd edition, 2002.
19. E. BenGershom, "Screening for albuminuria: A case for estimation of albumin in urine, " Clinical Chemistry, vol. 21, no. 12, pp. 1795-1798, 1975.
20. R. D. Perrone, N. E. Madias, and A. S. Levey, "Serum creatinine as an index of renal function: new insights into old concepts, " Clinical Chemistry, vol. 38, no. 10, pp. 1933-1953, 1992.
21. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, "Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man, " Diabetologia, vol. 28, no. 7, pp. 412-419, 1985.
22. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, "Protein measurement with the Folin phenol reagent, " The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265-275, 1951.
23. J. Folch, M. Lees, and G. H. Sloane-Stanley, "A simple method for the isolation and purification of total lipides from animal tissues, " The Journal of Biological Chemistry, vol. 226, no. 1, pp. 497-509, 1957.
24. J.-Q. Chen, T. R. Brown, and J. Russo, "Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors, " Biochimica et Biophysica Acta, vol. 1793, no. 7, pp. 1128-1143, 2009.
25. G. N. Wade and J. B. Powers, "Tamoxifen antagonizes the effects of estradiol on energy balance and estrous behavior in Syrian hamsters, " The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 265, no. 3, pp. R559-R562, 1993.
26. A. J. Bhatia and G. N. Wade, "Energy balance in pregnant hamsters: A role for voluntary exercise?" The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 265, part 2, no. 3, pp. R563-R567, 1993.
27. R. E. Stubbins, K. Najjar, V. B. Holcomb, J. Hong, and N. P. N͡nez, "Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance, " Diabetes, Obesity & Metabolism, vol. 14, no. 1, pp. 58-66, 2012.
28. Q. Gao, G. Mezei, Y. Nie et al., "Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals, " Nature Medicine, vol. 13, no. 1, pp. 89-94, 2007.
29. I. Pérez-Torres, B. Ibarra, E. Soria-Castro et al., "Effect of Glycine on the cyclooxygenase pathway of the kidney arachidonic acid metabolism in a rat model of metabolic syndrome, " Canadian Journal of Physiology and Pharmacology, vol. 89, no. 12, pp. 899-910, 2011.
30. R.C. Guerra, A. Z͡niga-M͡noz, V. Guarner Lans, E.Díaz-Díaz, C. A. Tena Betancourt, and I. Pérez-Torres, "Modulation of the activities of catalase, cu-zn, mn superoxide dismutase, and glutathione peroxidase in adipocyte from ovariectomised female rats with metabolic syndrome, " International Journal of Endocrinology, vol. 2014, Article ID 175080, 10 pages, 2014.
31. I. Pérez-Torres and G. Bãnos de MacCarthy, "Sex hormone receptors in metabolic syndrome, " in Sex Hormones: Development, Regulation andDisorders, vol. 1, chapter 3, pp. 53-74, Nova Science Publishers, 2011.
32. R. D. B͡nag, T. Tomita, and S. Sasaki, "Chronic sucrose ingestion induces mild hypertension and tachycardia in rats, " Hypertension, vol. 5, no. 2, pp. 218-225, 1983.
33. V. Guarner-Lans, M. E. Rubio-Ruiz, I. Pérez-Torres, and G. Bãnos de MacCarthy, "Relation of aging and sex hormones to metabolic syndrome and cardiovascular disease, " Experimental Gerontology, vol. 46, no. 7, pp. 517-523, 2011.
34. Y. Mendizábal, S. Llorens, and E. Nava, "Hypertension inmetabolic syndrome: vascular pathophysiology, " International Journal of Hypertension, vol. 2013, Article ID230868, 15 pages, 2013.
35. A. B. Hoffmamm, Sex Homones; Development, Regulation and Disorders, Endocrinology Research and ClinicalDevelopments, Nova Science, New York, NY, USA, 2011.
36. A. Dey, R. S. Williams, D. M. Pollock et al., "Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria, " Obesity Research, vol. 12, no. 8, pp. 1278-1289, 2004.
37. I. Pérez-Torres, V. Guarner, M. El Hafidi, and G. Bãnos, "Sex hormones, metabolic syndrome and kidney, " Current Topics in Medicinal Chemistry, vol. 11, no. 13, pp. 1694-1705, 2011.
38. C. C. S. Lemos, C. A. Mandarim-de-Lacerda, D. Dorigo, T. M. Coimbra, and R. Bregman, "Chronic renal failure in male and female rats, " Journal of Nephrology, vol. 18, no. 4, pp. 368-373, 2005.
39. M. Murakami, S. Shimbara, T. Kambe et al., "The functions of five distinct mammalian phospholipase A2s in regulating arachidonic acid release: type IIA and type V secretory phospholipase A2s are functionally redundant and act in concert with cytosolic phospholipase A2, " The Journal of Biological Chemistry, vol. 273, no. 23, pp. 14411-14423, 1998.
40. T. Di, J. A. Sullivan, H. L. Rupnow, R. R. Magness, and I.M. Bird, "Pregnancy induces expression of cPLA2 in ovine uterine artery but not systemic artery endothelium, " Journal of the Society for Gynecologic Investigation, vol. 6, no. 6, pp. 301-306, 1999.
41. J. A. Ospina, D. N. Krause, and S. P. Duckles, "17-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase, " Stroke, vol. 33, no. 2, pp. 600-605, 2002.
42. Y. Chawengsub, K. M. Gauthier, and W. B. Campbell, "Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone, "The American Journal of Physiology-Heart and Circulatory Physiology, vol. 297, no. 2, pp. H495-H507, 2009.
43. K. Kamata, M. Hosokawa, T. Matsumoto, and T. Kobayashi, "Altered arachidonic acid-mediated responses in the perfused kidney of the streptozotocin-induced diabetic rat, " Journal of Smooth Muscle Research, vol. 42, no. 5, pp. 171-187, 2006.
44. M. Matsuyama, T. Nakatani, T. Hase et al., "The expression of cyclooxygenases and lipoxygenases in renal ischemia-reperfusion injury, " Transplantation Proceedings, vol. 36, no. 7, pp. 1939-1942, 2004.
45. V. R. Holla, F. Adas, J. D. Imig et al., "Alterations in the regulation of androgen-sensitive Cyp 4amonooxygenases cause hypertension, " Proceedings of the National Academy of Sciences of theUnited States of America, vol. 98, no. 9, pp. 5211-5216, 2001.
46. P. Minuz, H. Jiang, C. Fava et al., "Altered release of cytochrome P450 metabolites of arachidonic acid in renovascular disease, " Hypertension, vol. 51, no. 5, pp. 1379-1385, 2008.
47. C. Pergola, G. Dodt, A. Rossi et al., "ERK-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthma, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 50, pp. 19881-19886, 2008.
48. M. K. Cheng, J. C. McGiff, and M. A. Carroll, "Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase, " The American Journal of Physiology-Renal Physiology, vol. 284, no. 3, pp. F474-F479, 2003.
49. P. Akarasereenont, K. Techatraisak, A. Thaworn, and S. Chotewuttakorn, "The induction of cyclooxygenase-2 by 17-estradiol in endothelial cells ismediated through protein kinase C, " Inflammation Research, vol. 49, no. 9, pp. 460-465, 2000.
50. M. Yang, C. Liu, J. Jiang et al., "Ginger extract diminishes chronic fructose consumption-induced kidney injury through suppression of renal overexpression of proinflammatory cytokines in rats, " BMC Complementary and Alternative Medicine, vol. 14, article 174, 12 pages, 2014.
51. A. Cignarella, M. Kratz, and C. Bolego, "Emerging role of estrogen in the control of cardiometabolic disease, " Trends in Pharmacological Sciences, vol. 31, no. 4, pp. 183-189, 2010.
52. J. D. Imig, "Eicosanoids and renal damage in cardiometabolic syndrome, "ExpertOpinion onDrugMetabolismandToxicology, vol. 4, no. 2, pp. 165-174, 2008.
53. R. A. Zeiss, R. L. Delmonico, A. M. Zeiss, and L. Dornbrand, "Psychologic disorder and sexual dysfunction in elders, " Clinics in Geriatric Medicine, vol. 7, no. 1, pp. 133-151, 1991.
54. C.-H. Chen, C. Booth-LaForce, H. Park, and S.-Y. Wang, "A comparative study of menopausal hot flashes and their psychosocial correlates inTaiwanandtheUnitedStates, " Maturitas, vol. 67, no. 2, pp. 171-177, 2010.